Kirjojen hintavertailu. Mukana 11 244 527 kirjaa ja 12 kauppaa.
Kirja.info

Kirjahaku

Etsi kirjoja tekijän nimen, kirjan nimen tai ISBN:n perusteella.

1000 tulosta hakusanalla D.B. RILEY

Integrated Disease Management of Chickpea Fusarium Wilt

Integrated Disease Management of Chickpea Fusarium Wilt

Sanjeev Kumar; Sangita Sahni; B D Prasad

Lap Lambert Academic Publishing
2023
pokkari
Chickpea (Cicer arietinum) is one of the world's major legume crops and suffers substantial damage from wilt disease incited by Fusarium oxysporum f. sp. ciceri (Padwick) with yield loss over 60 per cent. It is an important soil borne plant pathogen and is difficult to manage by application of chemical. Moreover, the chemical control is costly and leads to residual effect. In this book, an integrated approach using host plant resistance and integration of three components i.e., cultural (vermicompost amendment), chemical (ZnSO4 and Salicylic acid) and biological (seed bacterization with Pseudomonas spp.) were contemplated to manage this disease more effectively.
Vertaile hintoja
Integral and Differential Inclusions

Integral and Differential Inclusions

Afreen Siddiqui; Pravin More; B D Karande

Lap Lambert Academic Publishing
2023
pokkari
The method developed for proving existence the solution to the nonlinear differential and integral equations and inclusions is very much cumbersome and involves several technicalities present book deals with the theory of nonlinear differential, integral and integro-differential inclusions. This study includes integer as well as fractional order differential, integral and integro-differential inclusions in Banach Algebras. In the present work, we have mainly dealt with existence the solution as well as existence result for extremal solution to first, second and fractional order differential and integral inclusions in Banach Algebras.
Vertaile hintoja
The Creative Economy

The Creative Economy

Amanda J. Ashley; Carolyn G. Loh; Matilda Rose Bubb; Shoshanah B.D. Goldberg-Miller

TAYLOR FRANCIS LTD
2024
nidottu
The creative economy permeates our everyday lives, shaping where we live, what we buy, and how we interact with others. Looking at dimensions of people, place, policy, and market forces, the book offers a comprehensive perspective on arts and culture, in both economic and social life.The book explores the multifaceted components that make up this complex field. Underlying this journey is the throughline of diversity, equity, and inclusion as watchwords of today’s global paradigm. Capital, gentrification, pay disparities, and the hegemonic confines of cultural production are a few of the key issues analyzed. Using case studies and stories of artists and creatives from the worlds of fashion, design, music, and the media arts, the book also delves into gastronomy, literature, architecture, and theatre—presenting a nuanced look at the ways in which the creative sector impacts the world today. Readers will benefit from features such as key takeaways, discussion questions, and activities, throughout the chapters.Students, scholars, policymakers, and the general public will find this a valuable resource. This book offers the reader a chance not only to understand the cultural and creative industries, but to internalize its elements and embrace the creative spirit that imbues the sector.
Vertaile hintoja
The Creative Economy

The Creative Economy

Amanda J. Ashley; Carolyn G. Loh; Matilda Rose Bubb; Shoshanah B.D. Goldberg-Miller

TAYLOR FRANCIS LTD
2024
sidottu
The creative economy permeates our everyday lives, shaping where we live, what we buy, and how we interact with others. Looking at dimensions of people, place, policy, and market forces, the book offers a comprehensive perspective on arts and culture, in both economic and social life.The book explores the multifaceted components that make up this complex field. Underlying this journey is the throughline of diversity, equity, and inclusion as watchwords of today’s global paradigm. Capital, gentrification, pay disparities, and the hegemonic confines of cultural production are a few of the key issues analyzed. Using case studies and stories of artists and creatives from the worlds of fashion, design, music, and the media arts, the book also delves into gastronomy, literature, architecture, and theatre—presenting a nuanced look at the ways in which the creative sector impacts the world today. Readers will benefit from features such as key takeaways, discussion questions, and activities, throughout the chapters.Students, scholars, policymakers, and the general public will find this a valuable resource. This book offers the reader a chance not only to understand the cultural and creative industries, but to internalize its elements and embrace the creative spirit that imbues the sector.
Vertaile hintoja
The DelFly

The DelFly

G.C.H.E. de Croon; M. Perçin; B.D.W. Remes; R. Ruijsink; C. De Wagter

Springer
2015
sidottu
This book introduces the topics most relevant to autonomously flying flapping wing robots: flapping-wing design, aerodynamics, and artificial intelligence. Readers can explore these topics in the context of the "Delfly", a flapping wing robot designed at Delft University in The Netherlands.How are tiny fruit flies able to lift their weight, avoid obstacles and predators, and find food or shelter? The first step in emulating this is the creation of a micro flapping wing robot that flies by itself. The challenges are considerable: the design and aerodynamics of flapping wings are still active areas of scientific research, whilst artificial intelligence is subject to extreme limitations deriving from the few sensors and minimal processing onboard.This book conveys the essential insights that lie behind success such as the DelFly Micro and the DelFly Explorer. The DelFly Micro, with its 3.07 grams and 10 cm wing span, is still the smallest flapping wing MAV in the world carrying a camera, whilst the DelFly Explorer is the world's first flapping wing MAV that is able to fly completely autonomously in unknown environments. The DelFly project started in 2005 and ever since has served as inspiration, not only to many scientific flapping wing studies, but also the design of flapping wing toys.The combination of introductions to relevant fields, practical insights and scientific experiments from the DelFly project make this book a must-read for all flapping wing enthusiasts, be they students, researchers, or engineers.
Vertaile hintoja
The DelFly

The DelFly

G.C.H.E. de Croon; M. Perçin; B.D.W. Remes; R. Ruijsink; C. De Wagter

Springer
2019
nidottu
This book introduces the topics most relevant to autonomously flying flapping wing robots: flapping-wing design, aerodynamics, and artificial intelligence. Readers can explore these topics in the context of the "Delfly", a flapping wing robot designed at Delft University in The Netherlands.How are tiny fruit flies able to lift their weight, avoid obstacles and predators, and find food or shelter? The first step in emulating this is the creation of a micro flapping wing robot that flies by itself. The challenges are considerable: the design and aerodynamics of flapping wings are still active areas of scientific research, whilst artificial intelligence is subject to extreme limitations deriving from the few sensors and minimal processing onboard.This book conveys the essential insights that lie behind success such as the DelFly Micro and the DelFly Explorer. The DelFly Micro, with its 3.07 grams and 10 cm wing span, is still the smallest flapping wing MAV in the world carrying a camera, whilst the DelFly Explorer is the world's first flapping wing MAV that is able to fly completely autonomously in unknown environments. The DelFly project started in 2005 and ever since has served as inspiration, not only to many scientific flapping wing studies, but also the design of flapping wing toys.The combination of introductions to relevant fields, practical insights and scientific experiments from the DelFly project make this book a must-read for all flapping wing enthusiasts, be they students, researchers, or engineers.
Vertaile hintoja
Hepatitis B and D Protocols

Hepatitis B and D Protocols

Humana Press Inc.
2004
sidottu
Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.
Vertaile hintoja
Hepatitis B and D Protocols

Hepatitis B and D Protocols

Humana Press Inc.
2004
sidottu
Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.
Vertaile hintoja
Hepatitis B and D Protocols

Hepatitis B and D Protocols

Humana Press Inc.
2010
nidottu
Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.
Vertaile hintoja
1...4344454647...50